Sun Pharma slips over 2% after USFDA issues observations for Halol facility

Shares of Sun Pharmaceutical Industries slipped over 2 per cent lower at Rs 860.05 on the BSE in Tuesday's intra day trade. The decline comes after the company receieved 10 observations from the United States Food and Drug Administration (USFDA) after inspection of Sun Pharma's Halol (Gujarat, India) facility. 

In the past five days, the stock has fallen over 5 per cent. In comparison, the S&P BSE Sensex declined 3.75 per cent during the same period. Earlier, the stock had hit a 52-week high of Rs 966.90 that it had touched on April 29, 2022, whereas, slipped to 52-week